RE: Thoughts on upscale-SNG00119 Feb 2021 15:20
I agree, a lot of upscaling and agreements will be put in place. However, without approval or an EUA I very much doubt they have manufactured ANY yet for general use. All previous manufacturing will have concentrated on the trials and specific labelling for multiple languages and countries. I expect RM had to show sizeable sale up in order to be included in Activ2 but this can be done very quietly as long as they have the raw materials (IFN) and have reserved their vials slot.
I cant see them getting too far ahead of themselves when we haven't yet got approval. £30m was allocated to manufacturing but doesn't mean they've spent the whole lot and now have it sitting in warehouses ready to go. Scale up can happen very quickly when required and I expect all contracts are in place to make this happen. But ready to go stock on shelf, i'm not sure.